我要投票 大博集团在男科医院行业中的票数:366
· 外 推 电 报 ·
2025-08-12 10:53:25 星期二

【大博集团是哪个国家的品牌?】

大博集团是什么牌子?「大博集团」是 大博医疗科技股份有限公司 旗下著名品牌。该品牌发源于福建省厦门市,由创始人林 * 雄在2004年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力大博集团品牌出海!将品牌入驻外推网,定制大博集团品牌推广信息,可以显著提高大博集团产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

成立于2004年,以骨科、神经外科、微创外科为主的综合性医疗集团,与世界各地的专家建立良好的合作关系和经验交流


大博简介

大博医疗科技股份有限公司,成立于2004年,坐落于美丽的鹭岛——厦门,是一家以骨科、神经外科、微创外科为主的综合性医疗集团。公司先后通过了FDA、CE、ISO13485、GMP等专业认证,产品品质不断超越国际标准,得到国内外用户的一致认可。

研发制造

紧密结合临床,是大博开展研发工作的基石。经多年的钻研沉淀,与国内北上广等地的知名专家,以及澳大利亚、瑞士等国际专家,皆建立起良好的合作关系,广纳临床专家的实践经验,坚持不懈地进行产品和技术的提升与创新。同时,大博成立了厦门骨科医疗器械工程技术研究中心、与厦门大学联合成立厦大化工——大博医疗外科材料研发中心、同时还与台湾科技大学合办产学研项目,并承接多个科技项目。引进国际加工设备,以高度机械化的生产工艺,依托科学的质量管理体系,精心打造各种医疗产品,涵盖骨科、齿科、微创外科、神经外科、医用电子、医疗设备等。

营销网络

大博在产品、推广、服务等各方面进行创新,在全国多省均设有物流平台,构建便捷的物流网络。与近千家经销商通力合作,不断提高服务效率,及时地为3500余家医院提供优质的服务。同时,大博设立专业的“咨询服务与技术支持”团队,为客户提供医疗器械使用方法及技术要点咨询服务,解决医师在临床上遇到的困难和问题。“高品质,赢天下”。大博放眼全球,实行国际化战略布局,拥有涵盖英语、俄语、拉丁语等多语种的国际营销部门,产品直接出口至澳大利亚、瑞士、俄罗斯、乌克兰等20多个国家和地区。

发展战略

为配合企业前进的步伐,大博制定了四化发展战略:专业化——专攻医疗产品,只做业内前三;多元化——在医疗领域内实现产品多元化,打造综合性医用高值材料供应商;国际化——国际化发展战略,产品研发销售皆面向国际市场;创新化——产品研发、企业发展立足创新,推出创新性医疗产品,坚持以创新驱动发展企业。进行以产品为核心的研发、制造、教育、推广。


英文翻译:Founded in 2004, a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery, established a good cooperation relationship and experience exchange with experts from all over the world. Dabo Medical Technology Co., Ltd., founded in 2004, is located in Xiamen, the beautiful island of heron. It is a comprehensive medical group focusing on orthopedics, neurosurgery and minimally invasive surgery. The company has passed FDA, CE, ISO13485, GMP and other professional certification. The product quality continues to exceed international standards, and has been unanimously recognized by users at home and abroad. R & D and manufacturing are closely combined with clinical practice, which is the cornerstone of Dabo's R & D work. After years of research and precipitation, we have established good cooperation with well-known experts in China, Beijing, Shanghai, Guangzhou and other places, as well as international experts in Australia, Switzerland and other places. We have widely accepted the practical experience of clinical experts, and have been unremitting in product and technology upgrading and innovation. At the same time, Dabo has established Xiamen orthopedic medical device engineering technology research center, Xiamen University and Xiamen University to jointly establish Xiamen University chemical - Dabo medical surgical material research and development center. At the same time, Dabo and Taiwan University of science and technology jointly run production, teaching and research projects, and undertake a number of scientific and technological projects. With the introduction of international processing equipment, highly mechanized production process, and relying on scientific quality management system, we have carefully built various medical products, including orthopedics, dentistry, minimally invasive surgery, neurosurgery, medical electronics, medical equipment, etc. The marketing network is innovative in products, promotion, services and other aspects. It has logistics platforms in many provinces across the country to build a convenient logistics network. Cooperate with nearly 1000 distributors to improve service efficiency and provide quality services to more than 3500 hospitals in a timely manner. At the same time, Dabo has set up a professional "consulting service and technical support" team to provide customers with consulting services on the use methods and technical points of medical devices, so as to solve the clinical difficulties and problems encountered by doctors. "High quality, win the world". Dabo has a global perspective and an international strategic layout. It has an international marketing department covering English, Russian, Latin and other languages. Its products are directly exported to more than 20 countries and regions, including Australia, Switzerland, Russia, Ukraine and so on. Development strategy in line with the pace of enterprise progress, Dabo has formulated four development strategies: Specialization - specializing in medical products, only making the top three in the industry; diversification - realizing product diversification in the medical field, creating comprehensive medical high-value material suppliers; internationalization - international development strategy, product R & D and sales are oriented to the international market; innovation - Product R & D Based on innovation, the development of enterprises will launch innovative medical products and adhere to innovation driven development of enterprises. Carry out R & D, manufacturing, education and promotion with products as the core.

本文链接: https://www.waitui.com/brand/2fe6bfaf5.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

央行今日开展1146亿元7天期逆回购操作

36氪获悉,2025年8月12日中国人民银行以固定利率、数量招标方式开展了1146亿元7天期逆回购操作,操作利率1.40%。

54分钟前

OpenAI CEO:计划在未来5个月内将算力集群扩容一倍

OpenAI CEO OpenAI Sam Altman在X上表示:鉴于GPT-5带来的需求激增,我们在未来几个月的算力优先分配如下:1. 首先确保当前付费版ChatGPT用户的总可用量比GPT-5推出前更多。2. 其次优先满足API需求,直至达到当前分配的产能和已对客户做出的承诺。(粗略估计,以现有产能可在当前基础上再支持约30%的新API增长。)3. 提升ChatGPT免费版的服务质量。4. 再优先满足新的API需求。我们计划在未来5个月内将算力集群扩容一倍,因此这一情况有望改善。(新浪财经)

54分钟前

世界首台自动巡航杂交授粉育种机器人研制成功

我国在智能育种领域取得重要突破。中国科学院遗传与发育生物学研究所科研人员将生物技术和人工智能技术融合,改造作物花型,使其便于机器人操作的同时,成功研制出世界首台自动巡航杂交授粉育种机器人“吉儿”。这项突破解决了杂交育种的难题,可显著降低育种成本、缩短育种周期、提升育种效率。相关研究成果11日在线发表于《细胞》杂志。(科技日报)

54分钟前

米价上涨,韩国政府将首次“出借”储备米

韩国媒体11日报道,该国即将进入新米收获期,而市场供应趋紧引发米价上涨。韩国政府决定首次以“出借”方式向市场投放储备米,以平抑米价。近期,韩国米价呈上涨趋势。一项最新统计数据显示,截至8月,韩国一袋20公斤装大米平均零售价为5.8万韩元(约合300元人民币),较常年平均零售价高出逾10%,逼近6万韩元(约合310元人民币)价格阈值。(新华社)

54分钟前

高盛:截至6月,美消费者已消化约22%关税成本

当地时间11日,据美国《财富》杂志网站报道,美国高盛集团的研究显示,美国企业承担的美国加征关税的成本,正越来越多地转移到了美国消费者的身上。高盛表示,由于承担了美加征关税的成本,不少美国企业会抬高价格,减少损失,而这部分成本无疑将被转嫁至美国消费者的身上。高盛指出,截至6月份,美国消费者消化了大约22%的关税成本,如关税政策延续,这一数字可能在未来上升到67%。(央视新闻)

54分钟前

本页详细列出关于大博集团的品牌信息,含品牌所属公司介绍,大博集团所处行业的品牌地位及优势。
咨询